Cardiovascular effects of ritodrine are blocked by metoprolol in the anesthetized dog. 1985

R Gerritse, and P J Reuwer, and I M Pinas, and H J Beijer, and G A Charbon, and A A Haspels

Inhibition of ritodrine-induced cardiac and peripheral vascular effects by the beta 1-adrenergic blocker metoprolol, was studied by electromagnetic flow measurements in anesthetized dogs. As expected, metoprolol inhibited the ritodrine-induced/increased cardiac workload and heart rate. Metoprolol also inhibited ritodrine-induced peripheral vasodilation. This leads to questions about the cardiac beta 1-adrenergic selectivity of metoprolol. Regarding earlier studies showing no interference in labor inhibition, the combination of ritodrine and metoprolol might be useful in treatment of preterm labor, while economizing cardiovascular performance centrally as well as peripherally.

UI MeSH Term Description Entries
D008790 Metoprolol A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. Beloc-Duriles,Betaloc,Betaloc-Astra,Betalok,CGP-2175,H 93-26,Lopressor,Metoprolol CR-XL,Metoprolol Succinate,Metoprolol Tartrate,Seloken,Spesicor,Spesikor,Toprol,Toprol-XL,Beloc Duriles,Betaloc Astra,CGP 2175,CGP2175,H 93 26,H 9326,Metoprolol CR XL,Toprol XL
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

R Gerritse, and P J Reuwer, and I M Pinas, and H J Beijer, and G A Charbon, and A A Haspels
January 1961, Comptes rendus des seances de la Societe de biologie et de ses filiales,
R Gerritse, and P J Reuwer, and I M Pinas, and H J Beijer, and G A Charbon, and A A Haspels
May 1991, The Journal of pharmacology and experimental therapeutics,
R Gerritse, and P J Reuwer, and I M Pinas, and H J Beijer, and G A Charbon, and A A Haspels
January 1960, Comptes rendus des seances de la Societe de biologie et de ses filiales,
R Gerritse, and P J Reuwer, and I M Pinas, and H J Beijer, and G A Charbon, and A A Haspels
December 1976, Toxicology and applied pharmacology,
R Gerritse, and P J Reuwer, and I M Pinas, and H J Beijer, and G A Charbon, and A A Haspels
January 1978, Klinische Wochenschrift,
R Gerritse, and P J Reuwer, and I M Pinas, and H J Beijer, and G A Charbon, and A A Haspels
August 1970, Surgery,
R Gerritse, and P J Reuwer, and I M Pinas, and H J Beijer, and G A Charbon, and A A Haspels
December 1988, Journal of cardiovascular pharmacology,
R Gerritse, and P J Reuwer, and I M Pinas, and H J Beijer, and G A Charbon, and A A Haspels
August 1965, [Technical report] SAM-TR. USAF School of Aerospace Medicine,
R Gerritse, and P J Reuwer, and I M Pinas, and H J Beijer, and G A Charbon, and A A Haspels
April 1969, Cancer chemotherapy reports,
R Gerritse, and P J Reuwer, and I M Pinas, and H J Beijer, and G A Charbon, and A A Haspels
January 1985, Acta anaesthesiologica Scandinavica,
Copied contents to your clipboard!